Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 10X Genomics Inc (TXG) vs Yum China Holdings Inc (YUMC) Price & Performance

10X Genomics IncTrade
Yum China Holdings IncTrade

Price performance (Past 24H)

Key statistics

10X Genomics Inc vs Yum China Holdings Inc — how do they compare? 10X Genomics Inc trades at $67.59 (market cap $8.55B), while Yum China Holdings Inc trades at $42.55 (market cap $14.74B). The key difference: Yum China Holdings Inc is the larger of the two by market cap, and Yum China Holdings Inc pays a 2.68% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

TXGYUMC
Market Cap
$8.55B$14.74B
Sector
HealthConsumer Cyclical
52-Week High
$67.29$57.95
52-Week Low
$11.34$40.18
Enterprise Value
$8.08B$15.65B
Dividend Yield
2.68%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

10X Genomics Inc

TXG trades at $65.60, up 4.71% today, with a bullish technical signal and recent earnings beats. The stock shows improving fundamentals, with 2025 revenue at $642.82M and net loss narrowing to -$43.54M. Positive sentiment is driven by patent wins, Atera platform demand, and institutional interest, though valuation metrics like P/S of 13.58 and EV/EBITDA of 142.2 remain elevated.

Outlook is cautiously optimistic with upside potential from Atera execution, but risks include high valuation, persistent losses, and competitive pressures. Analyst consensus is mixed with a $50.56 price target below current levels, indicating near-term caution despite long-term growth prospects in genomics.

Yum China Holdings Inc

YUMC trades at $43.34, down 0.6% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported consistent earnings beats in recent quarters, with Q2 2026 EPS of $0.70 surpassing the $0.67 estimate. Revenue grew to $11.80 billion in 2025, and net income reached $929 million. Recent developments include the acquisition of Pizza Hut brand ownership in mainland China and expansion of the Pizza Hut Burger Bar to 300 locations.

The outlook remains positive given strong analyst support, with 14 buy ratings and a consensus pointing to 25.6% upside. Key risks include execution of expansion plans and macroeconomic pressures in China. The stock presents a value opportunity with a P/E of 15.88 and solid profitability metrics, but investors should monitor competitive dynamics and consumer spending trends.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG

About Yum China Holdings Inc

With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.

Read more on YUMC